CoreCap Advisors
INSM icon

CoreCap Advisors’s Insmed INSM Stock Holding History

CoreCap Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.4K Buy
21
+14
+200% +$1.65K ﹤0.01% 2456
2026
Q2 		$746 Buy
7
+5
+250% +$605 ﹤0.01% 2762
2026
Q1 		$327 Sell
2
-155
-99% -$23.8K ﹤0.01% 2709
2025
Q4 		$27.3K Buy
+157
New +$28.6K ﹤0.01% 1563
2025
Q2 		– Sell
-9
Closed -$687 – 2998
2025
Q1 		$687 Buy
+9
New +$688 ﹤0.01% 2606

Other funds holding INSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Axxion S.A.
Axxion S.A. Grevenmacher, Luxembourg $1.52B AUM
McRae Capital Management
McRae Capital Management Morristown, New Jersey $540M AUM 15.41% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

CoreCap Advisors's INSM Position: Q3 2026 in Review

CoreCap Advisors increased its Insmed (INSM) stake by 200% in Q3 2026, buying an estimated $1.65K and bringing the position to 21 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

CoreCap Advisors first reported a position in INSM in Q1 2025 and has held it in 5 quarters since. The position peaked at $27.3K in Q4 2025. 114 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • CoreCap Advisors held 21 shares of Insmed worth $2.4K as of Q3 2026.
  • CoreCap Advisors bought 14 Insmed shares in Q3 2026, an estimated $1.65K.
  • Insmed made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2456 holding.
  • CoreCap Advisors first reported a position in Insmed in Q1 2025 and has held it in 5 quarters since.
  • CoreCap Advisors's Insmed position peaked at $27.3K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.